Dyslipoproteinemia and diabetes

Endocrinology and Metabolism Clinics of North America

Volumn 27, Issue 3, 1998, Pages 613-625

  Garg, A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ESTROGEN; FIBRIC ACID DERIVATIVE; NICOTINIC ACID;

DIABETES MELLITUS; DIET; DRUG CHOICE; DRUG CONTRAINDICATION; DYSLIPIDEMIA; DYSLIPOPROTEINEMIA; ESTROGEN THERAPY; HUMAN; HYPERTRIGLYCERIDEMIA; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW;

EID: 0031719981     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70029-3     Document Type: Article

References (43)

1. N. Abate G.L. Vega A. Garg Abnormal distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM Atherosclerosis 118 1995 111 122
2. J.J. Abrams H. Ginsberg S.M. Grundy Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus Diabetes 31 1982 903 910
3. American Diabetes Association Management of dyslipidemia in adults with diabetes Diabetes Care 21 1998 179 182
4. American Diabetes Association Nutrition recommendations and principles for people with diabetes mellitus Diabetes Care 17 1994 519 522
5. M.A. Austin R.M. Krauss Genetic control of low density lipoprotein subclasses Lancet 1 1986 592 595
6. E. Barrett-Connor S.M. Grundy M.J. Holdbrook Plasma lipids and diabetes mellitus in an adult community Am J Epidemiol 115 1982 657 663
7. G. Ben L. Gnidi A. Maran Effects of chronic alcohol intake on carbohydrate and lipid metabolism in subjects with type II (non–insulin-dependent) diabetes Am J Med 90 1991 70 76
8. G.M. Chisolm K.C. Irwin M.S. Penn Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes Diabetes 41 1992 61 66
9. F.L. Dunn P. Raskin D.W. Bilheimer The effect of diabetic control on very low-density lipoprotein–triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia Metabolism 33 1984 117 123
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) JAMA 269 1993 3015 3023
11. C.J. Fielding G.M. Reaven G. Liu Increased free cholesterol in plasma low and very low density lipoproteins in non–insulin-dependent diabetes mellitus: Its role in the inhibition of cholesteryl ester transfer Proc Natl Acad Sci USA 81 1984 2512 2516
12. W.R. Fisher Heterogenity of plasma low density lipoproteins manifestations of the physiologic phenomenon in man Metabolism 32 1983 283 291
13. A. Garg Management of dyslipidemia in IDDM patients Diabetes Care 17 1994 224 234
14. A. Garg High-monounsaturated fat diets for patients with diabetes mellitus: A meta-analysis Am J Clin Nutr 67 suppl 1998 577S 582S
15. A. Garg S.M. Grundy Lovastatin for lowering cholesterol levels in non–insulin-dependent diabetes mellitus N Engl J Med 318 1988 81 86
16. A. Garg S.M. Grundy Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM Diabetes 38 1989 364 372
17. A. Garg S.M. Grundy Management of dyslipidemia in NIDDM Diabetes Care 13 1990 153 169
18. A. Garg S.M. Grundy Nicotinic acid as therapy for dyslipidemia in non–insulin-dependent diabetes mellitus JAMA 264 1990 723 726
19. A. Garg S.M. Grundy Cholestyramine therapy for dyslipidemia in non–insulin-dependent diabetes mellitus: A short-term, double-blind, crossover trial Ann Intern Med 121 1994 416 422
20. A. Garg S.M. Grundy Treatment of dyslipidemia in patients with NIDDM Diabetes Rev 3 1995 433 445
21. A. Garg S.M. Grundy Diabetic dyslipidemia and its therapy Diabetes Rev 5 1997 425 433
22. H. Glauber P. Wallace K. Griver Adverse metabolic effect of omega-3 fatty acids in non–insulin-dependent diabetes mellitus Ann Intern Med 108 1988 663 668
23. C.J. Glueck J. Lang T. Hamer Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women J Lab Clin Med 123 1994 59 64
24. A. Golay L. Zech M. Shi High density lipoprotein (HDL) metabolism in non–insulin-dependent diabetes mellitus: Measurement of HDL turnover using tritiated HDL J Clin Endocrinol Metab 65 1987 512 518
25. S.A. Haffner Management of dyslipidemia in adults with diabetes Diabetes Care 21 1998 160 178
26. S.M. Haffner L. Mykkanen M.P. Stern Greater effects of diabetes on LDL size in women than in men Diabetes Care 17 1994 1164 1171
27. B.V. Howard Lipoprotein metabolism in diabetes mellitus J Lipid Res 28 1987 613
28. B.V. Howard Pathogenesis of diabetic dyslipidemia Diabetes Rev 3 1995 423 432
29. A.H. Kissebah Low density lipoprotein metabolism in non–insulin-dependent diabetes mellitus Diabetes Metab Rev 3 1987 619 651
30. A.H. Kissebah S. Alfarsi D.J. Evans Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non–insulin-dependent diabetes mellitus Diabetes 31 1982 217 225
31. The Lipid Research Clinics The prevalence study Population Studies Data Book 1980 US Department of Health and Human Services Bethesda
32. T.J. Lyons Glycation and oxidation: A role in the pathogenesis of atherosclerosis Am J Cardiol 71 1993 26B 31B
33. National Cholesterol Education Program Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents Pediatrics 89 3 Pt 2 1992 525 584
34. F.Q. Nuttall Dietary fiber in the management of diabetes Diabetes 42 1993 503 508
35. Pyorala K. Pederson T.R. Kjekshus J. for The Scandinavian Simvastatin Survival Study (4S) Group Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care 20 1997 614 620
36. F.M. Sacks M.A. Pfeffer Moye L.A. the Cholesterol and Recurrent Events Trial Investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009
37. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
38. M.P. Stern J.K. Patterson S.M. Haffner Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey JAMA 262 1989 360 364
39. Taskinen M-R E.A. Nikkila T. Kuusi Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity Diabetologia 22 1982 46 50
40. M. Uusitupa O. Siitonon E. Voutilainen Serum lipids and lipoproteins in newly diagnosed non–insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels Diabetes Care 9 1986 17 22
41. P.W.F. Wilson W.B. Kannel K.M. Anderson Lipids, glucose intolerance and vascular disease: The Framingham study Monogr Atheroscler 13 1985 1 11
42. D.L. Wingard E. Barrett-Connor Heart disease and diabetes Harris M.I. Cowie C.C. Stern M.P. Diabetes in America 1995 National Institutes of Health Bethesda, MD 429 448
43. H. Yki-Jarvinen V.A. Koivisto R. Ylikahri Acute effects of ethanol and acetate on glucose kinetics in normal subjects Am J Physiol 254 1988 E175 E180